Home / Investments / U.S. Stocks Finish Higher After Promising Vaccine Study

U.S. Stocks Finish Higher After Promising Vaccine Study

About Debra Burns

Avatar

Check Also

Gilead Nears Deal to Buy Immunomedics for More Than $20 Billion

The biotech drugmaker has a market value of roughly $10 billion, meaning that Gilead would …

css.php